New Key Statistics Module, Z-Score and F-Score
SZSE:002581 Key Ratios
Market Cap ¥ M | 8,899.83 |
Enterprise Value ¥ M | 7,659.72 |
P/E(ttm) | -- |
PE Ratio without NRI | -- |
Forward PE Ratio | -- |
Price/Book | 4.26 |
Price/Sales | 21.88 |
Price/Free Cash Flow | -- |
Price/Owner Earnings | -- |
Payout Ratio % | -- |
Revenue (TTM) ¥ M | 406.00 |
EPS (TTM) ¥ | -0.53 |
Beneish M-Score | -2.93 |
10-y EBITDA Growth Rate % | -- |
5-y EBITDA Growth Rate % | -- |
y-y EBITDA Growth Rate % | -- |
EV-to-EBIT | -29.40 |
EV-to-EBITDA | -29.40 |
PEG | -- |
Shares Outstanding M | 659.74 |
Net Margin (%) | -85.57 |
Operating Margin % | -30.18 |
Pre-tax Margin (%) | -80.81 |
Quick Ratio | 9.93 |
Current Ratio | 11.18 |
ROA % (ttm) | -14.53 |
ROE % (ttm) | -16.30 |
ROIC % (ttm) | -6.31 |
Dividend Yield % | -- |
Altman Z-Score | 59.45 |
SZSE:002581 Number of Guru Trades
SZSE:002581 Volume of Guru Trades
Gurus Latest Trades with SZSE:002581
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
SZSE:002581 is held by these investors
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Shandong Sinobioway Biomedicine Co Ltd Insider Transactions
No Available Data